NYSE:AFL - Aflac Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $44.57
  • Forecasted Upside: -1.63 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$45.31
▲ +0.61 (1.36%)
1 month | 3 months | 12 months
Get New Aflac Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AFL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AFL

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$44.57
▼ -1.63% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Aflac in the last 3 months. The average price target is $44.57, with a high forecast of $56.00 and a low forecast of $35.00. The average price target represents a -1.63% upside from the last price of $45.31.
Hold
The current consensus among 8 polled investment analysts is to hold stock in Aflac. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
6/11/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/9/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 1 sell ratings
12/8/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/7/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 1 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
11/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
12/2/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2020Morgan StanleyBoost Price TargetEqual Weight$48.00 ➝ $49.00Low
i
10/6/2020Morgan StanleyBoost Price TargetEqual Weight$45.00 ➝ $46.00Low
i
9/22/2020Credit Suisse GroupBoost Price TargetNeutral$35.00 ➝ $40.00Low
i
7/30/2020SunTrust BanksLower Price TargetHold$44.00 ➝ $37.00Low
i
7/29/2020Morgan StanleyBoost Price TargetEqual Weight$42.00 ➝ $45.00Low
i
7/6/2020Morgan StanleyBoost Price TargetEqual Weight$40.00 ➝ $42.00Medium
i
5/1/2020SunTrust BanksLower Price TargetHold$54.00 ➝ $44.00Low
i
4/30/2020Morgan StanleyBoost Price TargetEqual Weight$38.00 ➝ $40.00High
i
4/27/2020Credit Suisse GroupLower Price TargetNeutral$45.00 ➝ $35.00Medium
i
4/17/2020Raymond JamesLower Price TargetOutperform$60.00 ➝ $50.00Low
i
Rating by Charles Peters at Raymond James
4/3/2020Piper SandlerLower Price TargetOverweight$47.00 ➝ $45.00Medium
i
3/20/2020Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform$46.00 ➝ $35.00N/A
i
3/17/2020Morgan StanleyLower Price TargetEqual Weight$54.00 ➝ $38.00Low
i
3/10/2020Piper SandlerLower Price TargetOverweight$55.00 ➝ $47.00Low
i
2/27/2020Piper SandlerLower Price TargetOverweight$60.00 ➝ $55.00High
i
1/23/2020Bank of AmericaReiterated RatingHold$56.00Low
i
Rating by Ian Ryave at Bank of America Co.
1/2/2020JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralMedium
i
12/5/2019Raymond JamesLower Price TargetBuy$62.00 ➝ $60.00Low
i
10/25/2019Bank of AmericaSet Price TargetHold$55.00Low
i
Rating by Ian Ryave at Bank of America Co.
10/10/2019UBS GroupBoost Price TargetNeutral$51.00 ➝ $53.00Low
i
9/27/2019Bank of AmericaSet Price TargetHold$54.00Medium
i
Rating by Ian Ryave at Bank of America Co.
8/23/2019BarclaysLower Price TargetEqual Weight$53.00 ➝ $49.00Medium
i
7/29/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$62.00Low
i
7/26/2019Morgan StanleyBoost Price TargetEqual Weight$53.00 ➝ $54.00Low
i
7/16/2019Evercore ISIDowngradeIn-Line ➝ Underperform$56.57Low
i
7/10/2019Morgan StanleyBoost Price TargetEqual Weight$51.00 ➝ $53.00Low
i
6/18/2019Raymond JamesBoost Price TargetStrong-Buy$56.00 ➝ $62.00Low
i
5/22/2019BarclaysBoost Price TargetEqual Weight$45.00 ➝ $53.00Low
i
4/30/2019Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$55.00 ➝ $56.00Medium
i
4/30/2019UBS GroupLower Price TargetNeutral ➝ Neutral$50.00 ➝ $49.00Medium
i
2/4/2019SunTrust BanksBoost Price TargetHold$48.00Low
i
1/2/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$51.00Medium
i
Rating by Jimmy Bhullar at JPMorgan Chase & Co.
11/13/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$48.00 ➝ $46.00Low
i
10/3/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
i
Rating by Jimmy Bhullar at JPMorgan Chase & Co.
9/27/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$47.00 ➝ $48.00Low
i
8/17/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$49.00 ➝ $45.00Low
i
Rating by Andrew Kligerman at Credit Suisse Group AG
8/7/2018B. RileyBoost Price TargetNeutral ➝ Neutral$42.00 ➝ $46.00Low
i
8/1/2018Sandler O'NeillUpgradeHold ➝ Buy$52.00Low
i
Rating by John Barnidge at Sandler O'Neill
8/1/2018Keefe, Bruyette & WoodsReiterated RatingHold$50.00Low
i
7/27/2018Sandler O'NeillSet Price TargetHold$50.00Low
i
Rating by John Barnidge at Sandler O'Neill
4/26/2018JPMorgan Chase & Co.Set Price TargetBuy$47.00Low
i
Rating by Jimmy Bhullar at JPMorgan Chase & Co.
4/25/2018Wells Fargo & CompanySet Price TargetHold$48.00Medium
i
Rating by Sean Dargan at Wells Fargo & Company
4/25/2018Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$49.00Low
i
4/5/2018Sandler O'NeillReiterated RatingHold$47.00Low
i
Rating by John Barnidge at Sandler O'Neill
3/27/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$22.75 ➝ $46.00Low
i
3/27/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$47.00Low
i
3/26/2018Bank of AmericaInitiated CoverageNeutral$49.00Low
i
3/21/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$45.00Low
i
3/2/2018UBS GroupInitiated CoverageNeutral$49.00Low
i
1/22/2018Raymond JamesUpgradeOutperform ➝ Strong-Buy$44.00 ➝ $50.00Low
i
1/22/2018CitigroupUpgradeStrong-Buy$44.00 ➝ $50.00Low
i
1/16/2018Janney Montgomery ScottReiterated RatingBuyLow
i
Rating by Larry Greenberg at Janney Montgomery Scott
1/9/2018Wells Fargo & CompanyReiterated RatingMarket Perform$42.00 ➝ $45.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
12/1/2017Wells Fargo & CompanySet Price TargetHold$42.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
11/6/2017B. RileyReiterated RatingNeutralN/A
i
Rating by R. Binner at B. Riley
10/25/2017Wells Fargo & CompanySet Price TargetHold$41.00N/A
i
Rating by Sean Dargan at Wells Fargo & Company
10/18/2017The Goldman Sachs GroupInitiated CoverageNeutral$44.00N/A
i
10/10/2017Royal Bank of CanadaReiterated RatingSell$35.50N/A
i
9/28/2017Wells Fargo & CompanyReiterated RatingHold$41.00Medium
i
9/26/2017CitigroupDowngradeNeutral ➝ Sell$41.00 ➝ $38.50Low
i
9/8/2017Bank of AmericaDowngradeNeutral ➝ UnderperformLow
i
Rating by Seth Weiss at Bank of America Co.
8/24/2017UBS GroupReiterated RatingOverweightLow
i
8/11/2017BarclaysBoost Price TargetEqual Weight$36.50 ➝ $39.50Low
i
7/12/2017FBR & CoReiterated RatingMarket Perform$34.00 ➝ $40.00Low
i
7/12/2017Royal Bank of CanadaReiterated RatingSell$33.00Low
i
7/4/2017Bank of AmericaUpgradeUnderperform ➝ Neutral$37.50 ➝ $39.00Low
i
Rating by Seth Weiss at Bank of America Co.
7/3/2017BarclaysBoost Price TargetEqual Weight$35.50 ➝ $36.50Low
i
5/1/2017Royal Bank of CanadaReiterated RatingUnderperform ➝ Underperform$31.00 ➝ $33.00Low
i
4/19/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$35.00 ➝ $36.00Low
i
4/18/2017Raymond JamesUpgradeMarket Perform ➝ Outperform$40.00Low
i
4/6/2017Bank of AmericaUpgradeUnderperform ➝ Neutral$37.50 ➝ $39.00Medium
i
4/3/2017JPMorgan Chase & Co.Boost Price TargetOverweight$37.50 ➝ $38.50Low
i
2/27/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$35.86 ➝ $37.50N/A
i
2/2/2017Royal Bank of CanadaReiterated RatingUnderperform$32.50 ➝ $31.00N/A
i
2/2/2017Royal Bank of CanadaLower Price TargetUnderperform$32.50 ➝ $31.00N/A
i
1/26/2017CitigroupInitiated CoverageNeutral$36.50N/A
i
1/11/2017Evercore ISIUpgradeSell ➝ HoldN/A
i
12/9/2016Royal Bank of CanadaDowngradeSector Perform ➝ Underperform$37.00 ➝ $32.50N/A
i
12/8/2016Royal Bank of CanadaDowngradeSector Perform ➝ Underperform$37.00 ➝ $32.50N/A
i
12/5/2016Deutsche Bank AktiengesellschaftReiterated RatingHoldN/A
i
10/28/2016FBR & CoReiterated RatingHoldN/A
i
Rating by Randy Binner at FBR & Co
10/7/2016Credit Suisse GroupInitiated CoverageUnderperform$37.50N/A
i
9/23/2016Wells Fargo & CompanyInitiated CoverageMarket PerformN/A
i
8/1/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$37.50 ➝ $36.50N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
8/1/2016UBS GroupReiterated RatingNeutral$35.50N/A
i
Rating by Suneet Kamath at UBS Group AG
7/29/2016FBR & CoReiterated RatingHoldN/A
i
Rating by Randy Binner at FBR & Co
7/7/2016Deutsche Bank AktiengesellschaftBoost Price TargetHold$35.50 ➝ $36.50N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
7/6/2016Evercore ISIInitiated CoverageSell$31.50N/A
i
7/6/2016JPMorgan Chase & Co.Reiterated RatingHoldN/A
i
5/26/2016FBR & CoDowngradeOutperform ➝ Market Perform$34.00N/A
i
Rating by Randy Binner at FBR & Co
5/23/2016Sandler O'NeillDowngradeBuy ➝ HoldN/A
i
Rating by John Barnidge at Sandler O'Neill
5/23/2016UBS GroupReiterated RatingHold$33.50N/A
i
5/22/2016CitigroupReiterated RatingBuyN/A
i
Rating by Erik Bass at Citigroup Inc.
5/20/2016Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$36.50N/A
i
5/10/2016FBR & CoDowngradeOutperform ➝ Market Perform$35.50 ➝ $34.00N/A
i
Rating by R. Binner at FBR & Co
4/27/2016UBS GroupBoost Price TargetNeutral$31.00 ➝ $33.50N/A
i
4/27/2016Royal Bank of CanadaReiterated RatingSector Perform$32.00 ➝ $33.50N/A
i
4/26/2016Morgan StanleyReiterated RatingHoldN/A
i
Rating by Nigel Dally at Morgan Stanley
4/21/2016Raymond JamesDowngradeOutperform ➝ Market PerformN/A
i
4/14/2016MacquarieUpgradeNeutral ➝ OutperformN/A
i
2/4/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$32.50 ➝ $32.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
2/4/2016CitigroupLower Price TargetBuy$35.50 ➝ $35.00N/A
i
Rating by Erik Bass at Citigroup Inc.
2/2/2016FBR & CoReiterated RatingOutperformN/A
i
2/2/2016BarclaysLower Price TargetEqual Weight$32.50 ➝ $30.50N/A
i
2/2/2016Piper Jaffray CompaniesReiterated RatingNeutral$37.50 ➝ $36.50N/A
i
Rating by John Nadel at Piper Jaffray Companies
2/2/2016Royal Bank of CanadaReiterated RatingSector Perform$33.00 ➝ $32.00N/A
i
1/25/2016Sandler O'NeillUpgradeHold ➝ BuyN/A
i
Rating by John Barnidge at Sandler O'Neill
1/14/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$34.00 ➝ $32.50N/A
i
1/13/2016The Goldman Sachs GroupLower Price TargetNeutral$32.00 ➝ $31.50N/A
i
12/11/2015Sandler O'NeillReiterated RatingHoldN/A
i
12/8/2015Raymond JamesLower Price TargetOutperform$36.00 ➝ $35.00N/A
i
12/4/2015BarclaysLower Price TargetEqual Weight$33.50 ➝ $32.50N/A
i
(Data available from 12/3/2015 forward)
Aflac logo
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.
Read More

Today's Range

Now: $45.31
$44.29
$45.55

50 Day Range

MA: $39.65
$33.95
$46.13

52 Week Range

Now: $45.31
$23.07
$54.04

Volume

3,633,399 shs

Average Volume

4,428,851 shs

Market Capitalization

$31.83 billion

P/E Ratio

7.08

Dividend Yield

2.55%

Beta

0.99